ERJ Open Research · Nov 9, 2026

Cardiovascular effects and mortality of short-acting bronchodilators in asthma and COPD

By Van Vaerenbergh F, Vauterin D, Bloom C et al.

BACKGROUND: Prior research has focused on short-acting β₂-agonist (SABA) overuse-related adverse outcomes in asthma patients. Evidence on the association between use of short-acting bronchodilators in general and cardiovascular events in asthma/COPD populations remains limited. METHODS: Adult patients with chronic treatment of asthma or COPD were identified in a Belgian nationwide cohort between 2017 and 2022. A Cox model adjusted for age, sex, smoking, socioeconomic status, exacerbation history, comorbidities and medication use, was used to investigate the association between SABA, short-acting muscarinic antagonist (SAMA) and SABA+SAMA use with cardiovascular risk and all-cause mortality. RESULTS: The cohort included 226 314 asthma patients (mean age 57.8 years, 60.5% females) and 57 446 COPD patients (mean age 72.2 years, 38.0% females). Compared with no use, SAMA and SABA+SAMA use (1-2 and ≥3 canisters per baseline year) was associated with increased heart failure (1.2-1.4-fold), arrhythmia (1.1-1.4-fold) and mortality risk (1.1-1.7-fold) in asthma and COPD patients. Among asthma patients, use of 1-2, and ≥3 SABA+SAMA canisters per year were additionally associated with increased myocardial infarction (1.2-1.4-fold) and ischaemic stroke risk (1.2-1.3-fold), and ≥3 SABA+SAMA canisters per year with a 1.4-fold myocardial infarction risk in COPD patients. Compared with no SABA users, ≥3 SABA canisters per year was associated with a 1.1-fold increased heart failure and mortality risk in asthma and COPD patients, while no increased risks were observed for 1-2 SABA canisters. CONCLUSION: Increased use of SAMA or SABA+SAMA was associated with increased risks of cardiovascular events and mortality in patients with asthma and COPD. Collecting three or more SABA canisters per year was associated with increased mortality.

doi.org/10.1183/23120541.00462-2026Open accessPubMed 43011614Populations

AgingResearch.News